Literature DB >> 1261771

Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II.

E R Gordon, E A Shaffer, A Sass-Kortsak.   

Abstract

Features characteristic of the Crigler-Najjar syndrome (type II) are described in an adolescent boy with severe congenital unconjugated hyperbilirubinemia. Bilirubin encephalopathy developed only in early puberty after surgery and fasting, coincident with a dramatic rise in serum bilirubin, which responded to intensive therapy. Fasting was later shown to increase markedly the serum bilirubin levels and probably was a major factor in precipitating the initial acute event. One year later, while the patient was in a metabolic steady state, the secretion rate of bilirubin was measured by aduodenal marker-perfusion technique, and the nature of the secreted bilirubin conjugates was characterized. Total bilirubin secretion rates were low, 4.39 mg per hr and 4.44 mg per hr on two separate studies. The major pigment detected in bile was bilirubin monoglucuronide. Bilirubin diglucuronide comprised only a minor fraction of the pigments, and other conjugates were not detected. The present study documents a reduced biliary bilirubin secretion and suggests that the addition of the second glucuronic acid moiety to the bilirubin molecule may be defective in Crigler-Najjar syndrome (type II).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261771

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.

Authors:  W S Lee; P J McKiernan; S V Beath; M A Preece; D Baty; D A Kelly; B Burchell; D J Clarke
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

2.  Bilirubin diglucuronide synthesis by a UDP-glucuronic acid-dependent enzyme system in rat liver microsomes.

Authors:  N Blanckaert; J Gollan; R Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  The use of jejunal transplants to treat a genetic enzyme deficiency.

Authors:  B M Jaffe; A A Burgos; M Martinez-Noack
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

4.  Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.

Authors:  B W Trotman; L Shaw; J Roy-Chowdhury; P F Malet; E F Rosato
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

5.  Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.

Authors:  J Fevery; N Blanckaert; K P Heirwegh; A M Préaux; P Berthelot
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

6.  Serum bile acids as related to bile acid secretion in liver disease.

Authors:  E A Shaffer; E R Gordon
Journal:  Am J Dig Dis       Date:  1978-05

7.  Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.

Authors:  S Güldütuna; U Langenbeck; K W Bock; A Sieg; U Leuschner
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

8.  Application of a rapid and efficient h.p.l.c. method to measure bilirubin and its conjugates from native bile and in model bile systems. Potential use as a tool for kinetic reactions and as an aid in diagnosis of hepatobiliary disease.

Authors:  W Spivak; W Yuey
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

9.  Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.

Authors:  E A Shaffer; D M Small
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

Review 10.  Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.